Janssen announced the results of two Program of Ulcerative Colitis Research Studies Utilizing and Investigational Treatment clinical studies recently published in Gastroenterology. The studies ...
HONG KONG – Xian Janssen Pharmaceutical Ltd. has launched Simponi (golimumab injection), making it the first once-monthly self-injectable anti-TNF biologic for patients with active ankylosing ...
U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned subsidiary of Johnson & Johnson, which manufactures and sells Remicade and ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the pharmacokinetics and ...
WHITEHOUSE STATION, N.J. & NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Johnson & Johnson (NYSE: JNJ) and its subsidiary Centocor ...
Alvotech (ALVO) and Advanz Pharma on Thursday said that the European Commission has granted marketing authorizations in the European Economic Area for Gobivaz, Alvotech’s biosimilar to Simponi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results